Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,630 | 1,620 | 720 | 800 | 1,260 |
| TOTAL | $1,630 | $1,620 | $720 | $800 | $1,260 |
| Non-Current Assets | |||||
| PPE Net | 700 | 740 | 840 | 910 | 880 |
| Other Non-Current Assets | 13,670 | 8,190 | 8,270 | 6,970 | 6,970 |
| TOTAL | $14,370 | $8,930 | $9,110 | $7,880 | $7,850 |
| Total Assets | $16,000 | $10,550 | $9,830 | $8,680 | $9,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,100 | 6,580 | 5,280 | 5,710 | 5,270 |
| Other current liabilities | 60 | 60 | 50 | 50 | 20 |
| TOTAL | $10,160 | $6,640 | $5,330 | $5,760 | $5,290 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,520 | 1,640 | 1,770 | 2,590 | 1,910 |
| TOTAL | $6,520 | $1,640 | $1,770 | $2,590 | $1,910 |
| Total Liabilities | $16,680 | $8,280 | $7,100 | $8,350 | $7,200 |
| Shareholders' Equity | |||||
| Common Shares | 290 | 220 | 220 | 220 | 220 |
| Other shareholders' equity | 20 | 60 | 60 | 120 | -580 |
| TOTAL | $465,320 | $451,580 | $450,980 | $450,690 | $450,140 |
| Total Liabilities And Equity | $482,000 | $459,860 | $458,080 | $459,040 | $457,340 |